Abstract:Peptide drugs are increasingly used to treat a variety of diseases ranging from cancer, and infections to cardiovascular diseases. However, peptides can suffer from low stability in the bloodstream. Entrapment of peptides into nano-sized carriers of various types has widely been explored, but all of them have spherical shapes. Nanocellulose can in contrast serve as a non-spherical nanoparticle with a high aspect ratio. After the isolation of nanocellulose by TEMPO-mediated oxidation, the material needs to be modified with polymers to generate nanoparticles with high water-solubility that can also favourably interact with peptide drugs. We have here chosen insulin as the model drug, which can strongly interact with cationic polymers. As it is known that cationic polymer may retain charged drugs too tightly, we have selected poly(2-(dimethylamino)ethyl acrylate) PDMAEA as a degradable polymer that undergoes self-hydrolysis to poly(acrylic acid) in water. This polymer was compared to poly(N-(3-(dimethylamino)propyl) acrylamide) PDMAPAA, which is a stable cationic polymer. The cationic polymer was co-grafted with poly(2-hydroxyethyl acrylate) PHEA as a water-soluble neutral polymer using the three-component Passerini reaction. A combination of fluorescence and UV-Vis techniques were used to quantify the amount of polymer that was conjugated to the surface. The polymer-coated nanocellulose was labelled with the fluorescent cyanine dye Cy5 while insulin was labelled with Cy3 creating a FRET system that allows monitoring of the interaction between insulin and polymer in cell growth media. We observed that despite the self-hydrolysis of PDMAEA into a negatively charged polymer, the negatively charged insulin was not released in buffer solution according to the FRET studies. Only the addition of serum-supplemented cell growth media led to insulin release. The limited release was explained with the fact that insulin, as well as other peptides, have a mixture of negative and positive charges, with the pH value and the isoelectric point determining the balance between both. Negative-charged polymers can therefore still interact favourably with negatively charged peptides by interacting with cationic amino acids.

Carboxymethyl Chitosan-Poly(amidoamine) Dendrimer Core–shell Nanoparticles for Intracellular Lysozyme Delivery

Bifunctional and Bioreducible Dendrimer Bearing a Fluoroalkyl Tail for Efficient Protein Delivery Both In Vitro and In Vivo

A Novel System for Water Soluble Protein Encapsulation with High Efficiency: “micelles Enhanced” Polyelectrolyte Capsules

A pH-Responsive Phase-Transition Polymer with High Serum Stability in Cytosolic Protein Delivery

A hyperbranched amphiphilic acetal polymer for pH-sensitive drug delivery

Core-Shell Nanoparticles Fabricated By Tri-Capillary Coaxial Electrospray And Template Removal Method For Protein Delivery

Preparation of Chitosan Coated Lysozyme-Poly(d,l-lacticco-glycolic Acid) Cationic Nanospheres

An Intracellular Ph-Actuated Polymer for Robust Cytosolic Protein Delivery

Reversible encapsulation of lysozyme within mPEG-b-PMAA: Experimental observation and molecular dynamics simulation

Rational Design of a Polymer with Robust Efficacy for Intracellular Protein and Peptide Delivery

Aldehyde Surface-Functionalized Shell Cross-Linked Micelles with pH-Tunable Core Swellability and Their Bioconjugation with Lysozyme

A non-spherical nanoparticles system for the delivery of peptides using polymer grafted nanocellulose

Boronic acid-rich dendrimer for efficient intracellular peptide delivery

Selective Cellular Uptake and Druggability Efficacy through Functionalized Chitosan-Conjugated Polyamidoamine (PAMAM) Dendrimers

Dynamic Polymer Amphiphiles for Efficient Intracellular and In Vivo Protein Delivery

A Coordinative Dendrimer Achieves Excellent Efficiency in Cytosolic Protein and Peptide Delivery.

pH/Redox/Lysozyme-Sensitive Hybrid Nanocarriers With Transformable Size for Multistage Drug Delivery

Nano Micelles of Cellulose-Graft-poly (L-Lactic Acid) Anchored with Epithelial Cell Adhesion Antibody for Enhanced Drug Loading and Anti-Tumor Effect

Chitosan Graft Copolymer Nanoparticles for Oral Protein Drug Delivery: Preparation and Characterization

Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery

Drug and Plasmid Dna Co-Delivery Nanocarriers Based on Abctype Polypeptide Hybrid Miktoarm Star Copolymers